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        A major function of NK cells is the specifi  c lysis 
of target cells, such as virally infected and tumor 
cells. The immunological synapse (IS) is formed 
at the contact site of immune cells and the cells 
they are recognizing. In the interaction between 
an NK cell and its target cell, an activating NK 
cell IS (NKIS) forms in distinct stages (  1, 2  ). 
The NKIS, which is similar to the IS in other 
cells, contains a supramolecular activation clus-
ter (SMAC). The SMAC is a distinct three-
  dimensional structure at the eff  ector  –  target cell 
interface with specifi  c clustering domains. In 
NK cell cytotoxicity, eff  ector  –  target conjugate 
formation occurs fi  rst, followed by the accu-
mulation of actin fi  laments and adhesion/acti-
vating receptors such as CD2 at the peripheral 
SMAC (pSMAC), and later by polarization of 
the microtubule organizing center and micro-
tubule-dependent lytic granule polarization to 
the central SMAC (cSMAC) (  2, 3  ). Polarization 
and exocytosis of lytic granules (a type of secre-
tory lysosome) are key events in mature NKIS 
formation and function, and they are necessary 
for NK cell cytotoxicity. 
  Reorganization of fi  lamentous actin (F-actin) 
is required for the formation of a mature lytic 
NKIS ( 2  ). Myosin motor proteins are also emerg-
ing as potentially important in IS formation. 
The myosin superfamily is thus far composed of 
at least 15 classes, with     40 members (  4  ). Myosins 
generate ATP-dependent movement along ac-
tin, and are regulated by phosphorylation. Non-
muscle myosin II, in particular, is believed to 
be involved in force generation within cells via 
F-actin contraction. It is a hexamer consisting 
of two heavy chains, each with an actin-  binding 
head region and a self-associating rodlike tail 
region with an     -helical coiled-coil motif, as 
well as two regulatory and two essential light 
chains. Initially, myosin was shown to play a 
role in molecular clustering at the T cell IS ( 5  ), but 
this work was performed using the relatively 
coarse inhibitor of myosin function 2,3-butane-
dione monoxime (BDM) (  6  ). The discovery of 
blebbistatin (1-phenyl-1,2,3,4-tetrahydro-4-hy-
droxypyrrolo[2.3-b]-7-methylquinolin-4-one), 
which is a specifi  c inhibitor of myosin II ATPase 
activity (  7  ), has facilitated the study of myosin II 
function in immune cells. Inhibition of myosin II 
by blebbistatin in CD4     T cells impairs cell mo-
tility, but not IS formation (  8  ). Moreover, inhi-
bition of myosin II with the myosin light chain 
kinase inhibitor ML-9 (1-[5-chloronaphthalene-
1-sulfonyl]-1H-hexahydro-1,4-diazepine hydro-
chloride) has been shown to inhibit NK cell 
cytotoxicity, but not eff  ector  –  target conjugation 
(  9  ). Myosin II is also especially relevant in NK 
cells because the myosin IIA isoform is recruited 
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target cell and was not aff  ected by either of the myosin II 
  inhibitors (  Fig. 2 A  ).   Next, the immunological synapse begins 
to mature. Important steps in this process are the accumula-
tion of F-actin and adhesion molecules in the NKIS, followed 
by the polarization of lytic granules (  2  ). As inhibition of actin 
by cytochalasin D blocks both of these steps in synapse forma-
tion (  2  ), it is plausible that myosin II could play a role in the 
approximation of F-actin networks and receptor clustering 
(  5, 16  ). However, inhibition of myosin II did not aff  ect the 
percentage of cells that accumulated actin, CD2, or perforin 
at the NKIS (  Fig. 2 B  ). The percentage of cells that accumu-
late perforin in the cSMAC is always less than the percentage 
of cells that accumulate actin or CD2 in the pSMAC (  2  ). Cell 
morphology and two-dimensional synapse structure were 
the same as previously published images (  Fig. 2 C   and Fig. 
S1 A, available at http://www.jem.org/cgi/content/full/jem
.20071143/DC1) (  2  ). Perforin, which is a component of and 
thus a marker for cytolytic granules, was clustered in the 
cSMAC, whereas actin and CD2 accumulated in the pSMAC. 
The appropriate localization of these key synapse proteins 
was also found in z sections, and the NKIS structure and size 
  appeared unaff  ected by inhibition of myosin II in both YTS 
and pNK cells (  Fig. 2 D   and Fig. S1 B). A ring of F-actin 
and CD2 in the pSMAC was clearly formed, with perforin in 
the cSMAC. Thus, inhibition of myosin II aff  ected NK cell 
eff  ector function neither at the point of conjugation with a 
target cell nor in the formation of the pSMAC (actin ring) 
and cSMAC (cytolytic granule polarization), indicating that 
myosin II may function in a step between the formation of the 
NKIS and the killing of the target cell. Correspondingly, confo-
cal microscopy of myosin II showed it to be primarily localized 
to a multiprotein complex formed during activating NKIS 
formation (  10  ). This complex contains at least seven proteins, 
including Wiskott-Aldrich syndrome protein (WASp), which 
is required for F-actin reorganization at the NKIS (  11  ). 
  Cytotoxic lymphocyte granule exocytosis is a unique cel-
lular process, but has numerous features in common with 
the process of directed vesicle secretion at the neural synapse. 
The process of neurotransmitter release involves several de-
fi  ned steps, including movement of vesicles to the active 
zone, docking of vesicles at the membrane, priming, fusion, 
and subsequent neurotransmitter release (  12  ). Although hun-
dreds of proteins are believed to be involved in neural vesicle 
exocytosis (  12  ), only four have thus far been identifi  ed in 
cytotoxic lymphocyte granule exocytosis (  13  ). These pro-
teins aff  ect granule exocytosis at the stages of granule polar-
ization (AP-3), docking (Rab27a), and priming (Munc13-4 
and syntaxin11). 
  We show that inhibition of myosin II with blebbistatin 
and other myosin inhibitors impairs neither eff  ector  –  target 
cell conjugation nor mature NKIS formation. However, they 
do inhibit membrane fusion of lytic granules, and thus also 
NK cell cytotoxicity. RNA interference (RNAi)  –  mediated 
knockdown of nonmuscle myosin IIA expression produces 
the same inhibitory eff  ect. Therefore, myosin II inhibition 
blocks a step between mature synapse formation and lytic 
granule fusion with the cell membrane (leading to exocytosis 
of granule contents), pointing to a specifi  c role for nonmuscle 
myosin IIA in NKIS function and showing it to be a fi  fth 
protein involved in lymphocyte lytic granule exocytosis. 
    RESULTS AND DISCUSSION   
  Myosin II inhibitors block NK cell cytotoxicity 
  NK cell cytotoxicity requires the integrated function of mul-
tiple cytoskeletal elements (  1, 2, 9, 11    ).   Nonmuscle myosin IIA 
was focused on because it was recruited to an actin-associated 
multiprotein complex in NK cells after activation by target 
cells (  10  ). Three diff  erent myosin II inhibitors (blebbistatin, 
ML-9, and BDM), which were each previously demonstrated 
to block myosin II function at the concentrations used (  6, 7, 15  ), 
blocked NK cell cytotoxicity in a   51  Cr release assay (  Fig. 1   
and not depicted).   ML-9 was previously shown to have this 
eff  ect  (  9  ). Both blebbistatin and ML-9 reduced cytotoxicity 
signifi  cantly compared with vehicle in several independent 
experiments, although YTS cells were more resistant than 
peripheral blood NK (pNK) cells. Although BDM also blocked 
NK cell cytotoxicity, only ML-9 and blebbistatin were used 
in further studies because of less overall specifi  city of BDM 
for myosin II (  6  ). 
  Evaluation of NKIS formation 
  Several key steps before target cell lysis are necessary for NK 
cell eff  ector function (  1, 2  ), and inhibition of any of these 
steps would decrease NK cell cytotoxicity. To elucidate 
where myosin II plays its critical role, NK cell eff  ector func-
tion was analyzed at each step. The fi  rst step is an adhesion 
molecule-mediated conjugation between the NK cell and 
  Figure 1.     Inhibition of myosin II blocks NK cell cytotoxicity. pNK 
cells and YTS cells were pretreated with inhibitors, and their killing ability 
was assayed using   51  Cr release from K562 or 721.221 target cells, respec-
tively. DMSO was used as a solvent for blebbistatin (Bleb; A) and EtOH was 
used as a solvent for ML-9 (B), and they are the control curves for their 
respective inhibitors. Both solvents showed nonspecifi  c effects on cyto-
toxicity. Specifi  cally, at an E/T ratio of 10:1 DMSO at the concentration 
used reduced killing of pNK cells by 18% and of YTS cells by 0%, whereas 
EtOH at the concentration used reduced killing of pNK cells by 52% and 
of YTS cells by 15%. Each curve represents the mean      the SD of three 
independent experiments. *, P      0.05 and **, P      0.01  by  Student ’ s   t   test.   JEM VOL. 204, October 1, 2007  2287
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granule exocytosis were examined. First, cell surface CD107a 
(LAMP-1), which is found on the lumenal surface of intra-
cellular lytic granules that are derived from lysosomes, was 
measured. When lytic granules fuse with the cell membrane, 
the lumenal surface becomes part of the cell surface (  17  ). 
Thus, surface expression of CD107a was used as a marker 
for granule fusion with the cell membrane upon stimulation 
of the NK cells. Activation of YTS cells with either PMA/
ionomycin or with 721.221 target cells yielded a small in-
crease in surface CD107a that was inhibited by treatment 
with myosin II inhibitors (  Fig. 3 A  ).   However, pNK cells 
showed a much larger increase in CD107a expression upon 
treatment with PMA/ionomycin, as previously described (  17  ). 
in the cortex with F-actin, as expected, because myosin II 
is a primarily F-actin  –  interacting protein (  Fig. 2 E  ). However, 
a small amount of myosin II was found to be colocalized with 
granules as well, along with F-actin, indicating that some myosin 
II is localized in a position where it can participate in the termi-
nal steps of granule-mediated cytotoxicity. 
  Inhibition of granule exocytosis 
  After lytic granule polarization to the synapse, granule fusion 
with the NK cell membrane occurs, followed by perforin and 
granzyme release (exocytosis) and eventual target cell lysis. 
Because myosin inhibitors blocked cytotoxicity, but not acti-
vating NKIS formation, the eff  ects of myosin II inhibition on 
  Figure 2.     Myosin II inhibition does not affect conjugation or mature lytic synapse formation. (A) YTS-GFP cells were incubated with 721.221-
RFP cells, and conjugation was quantifi  ed by FACS. Conjugates were defi  ned as the percentage of GFP, RFP double-positive events measured by FACS 
compared with those seen with YTS-GFP cells alone. (B) The accumulation of F-actin, perforin, and CD2-GFP (YTS cells) or CD2-FITC (pNK cells) at the IS 
of an effector  –  target conjugate pair was evaluated for 50 conjugates in each experiment. Values are expressed as the percentage of synapses at which 
fl  uorescence was accumulated. Bar graphs represent the mean      the SD of three independent experiments. (C) pNK cells are shown conjugated with 
K562 cells (top), and YTS-CD2-GFP cells are shown conjugated with 721.221 cells (bottom). NK cells are the top cells and target cells are the bottom cells 
in the conjugate pair. Differential interference contrast images are in the left column and fl  uorescent images are in the right columns. A merged overlay 
of all fl  uorescent channels is in the fi  fth column. (D) Representative lytic synapses were evaluated throughout their volume, and the z, x plane was recon-
structed. The fi  rst row shows a lytic synapse in a pNK cell conjugated with a K562 cell. The bottom two rows show lytic synapses between YTS-CD2-GFP 
cells and 721.221 cells. The fi  nal column is a merged overlay of the fl  uorescent channels from the fi  rst three columns. The different inhibitor treatment 
for each row is indicated on the left of both C and D. In the case of both C and D, vehicle control images were identical in each case to those where NK 
cells were treated with inhibitors (solvent control for C and D are found in Fig. S1). (E) Myosin IIA colocalizes with F-actin and perforin. Representative 
conjugate pairs of both a YTS cell and a 721.221 target cell (top), as well as a pNK cell with a K562 cell (bottom) are shown, in the same format as 
C. Myosin II is found to associate with F-actin, as well as granules (white arrowhead). Bars, 5    m.   2288 NK CELL GRANULE EXOCYTOSIS REQUIRES MYOSIN IIA | Andzelm et al.
Serine esterase activity (which is an assay for granzymes) was 
signifi  cantly decreased in both cases when stimulated pNK 
cells were fi  rst preincubated with blebbistatin (  Fig. 3 C  ), indi-
cating that, as expected, a lack of granule fusion leads to a lack 
of granule content release. 
  These results are particularly important in defi  ning a key 
role for myosin II in granule exocytosis independent of other 
steps in NK cell cytotoxicity. Although synapse formation 
and conjugation were unimpaired, further experiments are 
required to fully evaluate the eff  ect of myosin II inhibition on 
NK cell motility, especially as myosin IIA has previously been 
shown to regulate the motility of CD4     T cells (  8  ). How-
ever, both treatment with PMA/ionomycin that is uniformly 
distributed within media and interaction with anti-CD16 
mAb-coated plates are motility independent. 
  RNAi-mediated myosin IIA knockdown impairs NK cell 
cytotoxicity and granule exocytosis 
  Although the specifi  city of blebbistatin for nonmuscle myo-
sin II may implicate it, several isoforms of myosin II exist 
with diff  ering eff  ects. Although myosin IIA was the isoform 
identifi  ed as a component of the WIP  –  WASp  –  containing 
multiprotein complex at the synapse by vMALDI tandem 
mass spectroscopy (  10  ), a smaller amount of myosin IIB was 
also seen by Western blot (unpublished data). In this light, 
nonmuscle myosin IIA and IIB have been shown to have 
distinct roles in vesicle exocytosis during cell membrane 
  repair in fi  broblasts (  20  ). Myosin IIA had a proposed role in 
vesicle traffi   cking, and IIB in membrane resealing. Thus, to 
confi  rm the inhibitor specifi  city, and to look at the isoform-
specifi  c function of myosin II, RNAi knockdown of myosin 
IIA was performed in NKL cells, which also have reduced 
killing ability in the presence of blebbistatin (  Fig. 4 A  ).   NKL 
cells infected with the lentivirus for myosin IIA RNAi had a 
    80% reduction in myosin IIA protein expression relative 
to WASp expression (  Fig. 4 B  ) compared with the pLKO 
vector-only control. Furthermore, myosin IIA mRNA expres-
sion was reduced by     75% as assessed by semiquantitative 
RT-PCR, whereas mRNA transcript levels of other proteins 
involved in granule exocytosis (syntaxin11, Munc-13-4, and 
Rab27a) were unaff  ected (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20071143/DC1). Cytotoxi-
city was also impaired by     50%, which is comparable to the 
extent of myosin IIA knockdown (  Fig. 4 C  ). Granule exo-
cytosis was impaired to approximately the same extent, as 
  assessed by lytic granule fusion with the cell membrane mea-
sured by CD107a surface expression (  Fig. 4 D  ), as well as by 
serine esterase release (  Fig. 4 E  ). Cell morphology and prolif-
erative capacity remained similar to control cells. 
  These results demonstrate the key role that myosin IIA 
plays in NK cell eff  ector function at some step between 
lytic granule polarization and granule exocytosis. However, 
the nature of this step remains to be defi  ned, and there are 
several possibilities. In particular, the interaction between 
myosin IIA and actin could be force generating and facili-
tate vesicle fusion. Myosin II has already been hypothesized 
This expression was signifi  cantly reduced after myosin II in-
hibition (  Fig. 3 B  ). Thus, myosin II plays a role in the fusion 
of lytic granules with the NK cell membrane. 
  After granule fusion, the contents of the granules, most 
importantly perforin and granzymes, are released into the 
  immunological synapse (  18  ). CD16 (Fc    RIIIA), which is pre-
sent on a majority of pNK cells, renders them strong mediators 
of antibody-dependent cellular cytotoxicity on IgG  –  coated 
target cells. Moreover, this process results in a robust degranu-
lation in the absence of target cells (  19  ). Thus, stimulation by 
anti-CD16, as well as by K562 target cells, was used to acti-
vate pNK cells and induce granule release into the supernatant. 
  Figure 3.     Myosin II inhibitors block lytic granule exocytosis. 
(A) pNK and YTS cells were activated with either their respective target 
cells or PMA and ionomycin (Iono). The percentage of increase in CD107a 
surface expression was evaluated by FACS and expressed as the increase 
over identically treated (including with appropriate inhibitors) unstimu-
lated cells. Thus, unstimulated cells were used as a baseline to account for 
any nonspecifi  c stimulation of antibody endocytosis or granule exocytosis 
over the incubation time, as well as any antibody endocytosis nonspecifi  -
cally induced by cell treatment. Unstimulated cells also accounted for any 
potential shifts in fl  uorescence caused by drug color. Bar graphs represent 
the mean      the SD of three independent experiments. (B) A representative 
histogram of CD107a surface expression from pNK cells stimulated with 
PMA/ionomycin      blebbistatin. The percentage of pNK cells expressing 
a high level of CD107a was gated, and values are shown on the graph. 
The percentage of Max indicates the number of events at each given 
fl  uorescence intensity, where the intensity with the greatest number of 
cells has been normalized to be 100%. (C) pNK cells were stimulated by 
plate-bound anti-CD16 or K562 target cells, and their supernatant was 
used in a serine esterase assay. Results are expressed as a percentage of 
total release from cells pretreated with inhibitors or appropriate controls 
to account for possible background effects on the colorimetric assay 
caused by either intrinsic compound color or direct effects on serine 
  esterase activity. Bar graphs represent the mean      the SD of four to fi  ve 
independent experiments. Paired and unpaired Student  ’  s   t   tests were per-
formed to obtain P values.     JEM VOL. 204, October 1, 2007  2289
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transport (  21  ), and thus may also have a cooperative role with 
microtubule motors. 
  Myosin IIA may therefore play a role in vesicle move-
ment close to the synapse, and although z sections do not 
show a disrupted cSMAC or pSMAC, myosin IIA inhibition 
may have a more subtle eff  ect on granule alignment within 
the actin ring, disrupting vesicle docking, priming, or fusion 
with the membrane. In that case, the defi  ciency could be 
similar to that seen in the mouse model of Griscelli syndrome 
(ashen), which is a Rab27a defi  ciency where CTL lytic gran-
ules become trapped behind the Golgi apparatus and fail to 
dock at the plasma membrane (  24  ). Alternatively, myosin IIA 
may play a role in vesicle priming, as Munc13-4 does in CTL 
as found in patients with familial hemophagocytic lympho-
histiocytosis 3 (  25  ). NK cells in Munc13-4  –  defi  cient patients 
have also been found to have lower cytotoxicity caused by 
impaired granule fusion with the membrane, whereas granule 
polarization was unaff  ected (  26  ). Similarly, a role for myosin 
IIA in lytic granule exocytosis has been defi  nitively demon-
strated here. 
    MATERIALS AND METHODS   
  Cells and inhibitors.     The NKL (  27  ) and YTS NK cell lines, YTS cells ex-
pressing the mouse ecotropic receptor (YTS-Eco), and YTS stably express-
ing GFP (YTS-GFP) or a CD2-GFP fusion protein (  2  ) were used as model 
NK cell systems. Leukocyte-enriched peripheral blood was obtained from 
Massachusetts General Hospital or the Dana-Farber Cancer Institute with 
Institutional Revue Board approval, and ex vivo pNK cells were prepared by 
treatment with Rosette-Sep NK (StemCell Technologies) and subsequent 
separation via centrifugation through Ficoll-Paque (GE Healthcare). K562 
erythroleukemia, 721.221 B-lymphoblastoid cells, or 721.221 cells express-
ing RFP (RFP-221; all MHC class I  –  negative) were used as target cells. 
  NK cells were preincubated with the following inhibitors for 30  –  60 min 
at 37  °  C, where indicated: 80     M ML-9 (Sigma-Aldrich) in 0.6% EtOH, 
20 mM BDM (Sigma-Aldrich) in 2% MeOH, and 75     M blebbistatin 
(Toronto Research Chemicals) in 0.3  –  3.3% DMSO. 
  Myosin IIA RNAi.     Two DNA oligos designed to produce the shRNA 
targeting the sequence 5  	  -GGGACTTGTCCCAAGTCTGAC-3  	   in the 
3  	  UTR of the myosin IIA gene were inserted into the pLKO.3G (pLKO) 
vector containing an ampicillin resistance gene (a gift from D. Mathis and 
C. Benoist, Joslin Diabetes Center, Boston, MA). The constructed plasmids, 
together with envelope gene  –  encoding plasmids pHR  ’  -CMV-  
  R8.20vpr 
and pHR  ’  -CMV-VSV-G (a gift from R. Erikson, Harvard University, 
Cambridge, MA) were transfected into a 293T packaging cell line using 
  FuGENE 6.0 Transfection Reagent (Roche) to produce recombinant lenti-
virus. Harvested virus was mixed with 8     g/ml polybrene (Sigma-Aldrich) 
and used to infect NKL cells. Lentivirus-infected cells were selected by GFP 
expression with fl  ow cytometry, and myosin IIA expression was assessed by 
Western blot (  10  ) and semiquantitative RT-PCR. 
  Semiquantitative RT-PCR.     Total mRNA was extracted from lentivirus-
infected NKL cells, quantifi  ed, and diluted to a concentration of 100 ng/ml. 
After reverse transcription, PCR was performed in limiting dilutions of 1/25 
and 1/125 using the Thermoscript RT-PCR kit (Invitrogen). Primers used 
for the evaluation of myosin IIA heavy chain (  MYH9)   expression were 
5  	  -CAAAGGAGCCCTGGCGTTAGAG-3  	   and 5 	  -CCCCATCCGCTTT-
GCCATCTAC-3  	  . For hMunc13-4, the primers used were 5  	  -TACTTCT-
GCAGCCGAATCCA-3  	   and 5  	  -CCCAGCGTGTCGTAGTCCA-3  	  . 
For hRab27a, the primers used were 5  	  -ATGTCTGATGGAGATTATGAT-
TACCTC-3  	   and 5  	  -TTGCTTGGCTTATGTTTGTCCCATTGGCA-3  	  . 
to play a role in the fusion dynamics of chromaffi   n cells by 
infl  uencing the kinetics of exocytotic pore expansion (  21  ), 
and it could have a similar role in this study. Myosin light 
chain kinase, which is a key regulator of myosin II, has also 
been implicated in vesicle release at neural synapses (  22  ) and 
the ATP-dependent priming of exocytosis in chromaffi   n 
cells (  23  ), further indicating that myosin II may play a key 
role in vesicle fusion. 
  Alternatively, myosin IIA could help build a bridge be-
tween two cytoskeletal proteins. In the NKIS, microtubules 
bring lytic granules when they polarize to a synapse that has 
already accumulated F-actin. Conceivably, myosin IIA could 
help lytic granules approach the synapse more closely than 
they are able to while attached to microtubules, and posi-
tion them close enough to fuse with the NK cell membrane. 
Myosin II also appears to have an important role in vesicle 
  Figure 4.     Knockdown of myosin IIA in NKL cells impairs cytotoxi-
city and granule exocytosis. (A) NKL cells were pretreated with bleb-
bistatin, and killing ability was assayed using   51  Cr release from 721.221 
target cells. (B) Relative protein levels were assessed after RNAi of myosin 
IIA by Western blot with WASp content as the control. (C) Killing ability 
of NKL cells with myosin IIA knockdown was assayed using the same   51 Cr 
release assay. NKL cells infected with the pLKO vector only were used as a 
control. *, P      0.1, **, P      0.04, and **, P      0.02  by  Student ’ s   t   test  for 
both graphs. (D) The percentage of increase in CD107a surface expression 
was evaluated by FACS and expressed as the increase over identically 
treated cells, but with no stimulation by PMA and ionomycin (Iono). 
(E) NKL cells were stimulated by PMA and ionomycin or 721.221 target cells, 
and their supernatant was used in a serine esterase assay. Results are 
expressed as a percentage of total release. All data represent the mean     
the SD of three independent experiments. Unpaired Student  ’  s   t   tests  were 
performed to obtain P values.     2290 NK CELL GRANULE EXOCYTOSIS REQUIRES MYOSIN IIA | Andzelm et al.
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For hSyntaxin11, the primers used were 5  	  -ACTACAACCAGGCCGAGA-
TGAA-3  	   and 5  	  -TTGTACGTTGAGCTCGATGACG-3  	  . For hHPRT, 
the primers used were 5  	  -CCTGCTGGATTACATTAAAGCACTG-3  	   and 
5  	  -GTCAAGGGCATATCCAACAACAAAC-3  	  . 
  NK cell functional assays.     Cytolytic activity was assayed by   51  Cr release 
assay, as previously described (  11  ). 
  To measure conjugation, YTS-GFP cells (5      10  6   cells/ml) were mixed 
with an equal amount of RFP-221 cells, combined by centrifugation at 200   g   
for 1 min, and incubated at 37  °  C for 20 min. Cells were then fi  xed with 0.5% 
paraformaldehyde and evaluated by FACS. 
  To determine CD107a (LAMP-1) surface expression, YTS cells were 
mixed at a 1:1 ratio with target cells, 2.5     g/ml PMA (Sigma-Aldrich), 0.5     g/
ml ionomycin (Sigma-Aldrich), or only media for 6 h at 37  °  C in the pres-
ence of PE-conjugated anti-CD107a mAb (BD PharMingen), after which 
cells were washed and resuspended in PBS  1% BSA. 3 mM monensin 
(Golgi-Stop; BD PharMingen) was added after the fi  rst hour. pNK cells were 
treated similarly, except for a 4-h incubation with 2 ng/ml PMA, 0.5     g/ml 
ionomycin, and 0.6 mM. Monensin was used and cells were resuspended in 
PBS  2% BSA and 0.5 mM EDTA. Both cell types were incubated with 
FITC or APC-conjugated CD56 mAb (BD PharMingen) on ice for 30 min, 
washed twice, fi  xed with 1% paraformaldehyde, and evaluated by FACS. 
GFP-expressing NKL cells were stimulated with 20 ng/ml PMA, 0.5     g/ml 
ionomycin for 4 h at 37  °  C in the presence of PE-conjugated anti-CD107a 
mAb (BD PharMingen), washed, resuspended in PBS + 2% BSA and then 
evaluated by fl  ow cytometry. Only GFP-positive cells were included in the 
analysis. Unstimulated NK cells were used as a negative control for all cell 
lines. Equal numbers of events were collected for both unstimulated and 
stimulated samples, as well as for control and experimental NK cell lines. 
  N    -benzyloxycarbonyl-L-lysine thiobenzyl ester assay for serine esterase 
was performed as previously described (  14  ), except that pNK cells were pre-
incubated at least overnight with 100 U/ml IL-2. PNK cells were stimulated 
with plate-bound anti-CD16 and K562 target cells (E/T ratio 1:1). NKL cells 
were stimulated with 20 ng/ml PMA and 0.5     g/ml ionomycin, and 721.221 
target cells. Stimulation was for 5 h at 37  °  C. Total release was obtained by 
repeated freeze  –  thaw of NK cells. 
  Confocal microscopy.     Confocal microscopy was performed as previously 
described (  2  ), except that rabbit anti  –  human myosin IIA (Sigma-Aldrich) 
and goat anti  –  rabbit (Invitrogen) were additionally used. For evaluation of 
synapses throughout their volume, 20  –  30 images were acquired through 
the z axis at 0.5  –  1-    m intervals (total volume of z, x reconstructions was 
10  –  20     m). 
  Online supplemental material.     Fig. S1 shows that NK cells preincubated 
with solvent alone form normal two- and three-dimensional mature lytic 
synapses identical to inhibitor-treated cells. Fig. S2 shows that myosin IIA 
RNAi reduces the expression of myosin IIA mRNA in NK cells, but not 
that of the granule exocytosis  –  related proteins hSyntaxin11, hRab27a, and 
hMunc13-4. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20071143/DC1. 
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